CT-2584 mesylate April 12, 2017 CT-2584 mesylate Trade Name Orphan Indication Malignant mesothelioma USA Market Approval USA USA Designation Date 1999-04-16 00:00:00 Sponsor Cell Therapeutics, Inc.;501 Elliott Avenue West, #400;Seattle, Washington, 98119
